Zobrazeno 1 - 10
of 41
pro vyhledávání: '"N. T. Mathew"'
Autor:
S D, Silberstein, D W, Dodick, A S, Lindblad, K, Holroyd, M, Harrington, N T, Mathew, D, Hirtz, Leigh Anne, Kreshel
Publikováno v:
Neurology. 78:976-984
Objective: To assess the efficacy and safety of adding propranolol to topiramate in chronic migraine subjects inadequately controlled with topiramate alone. Methods: This was a double-blind, placebo-controlled, randomized clinical trial conducted thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d514553aa28e136ae66e4bac5dd12064
https://doi.org/10.1212/wnl.0b013e31824d5846
https://doi.org/10.1212/wnl.0b013e31824d5846
Publikováno v:
International Journal of Clinical Practice. 60:698-706
Most of the data on triptan use are from clinical trials in which patients were instructed to wait until migraine headache pain was moderate/severe in intensity. In the real world, patients may hesitate to use a triptan until headache pain is moderat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a39e205f341fb2af4cb100b8a44fec0
https://doi.org/10.1111/j.1742-1241.2006.00981.x
https://doi.org/10.1111/j.1742-1241.2006.00981.x
Autor:
N. T. Mathew
Publikováno v:
Textbook of Stereotactic and Functional Neurosurgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b7c774f0c2469d11fdff6f752d60f63
https://doi.org/10.1007/978-3-540-69960-6_146
https://doi.org/10.1007/978-3-540-69960-6_146
Publikováno v:
Cephalalgia : an international journal of headache. 20(8)
Through December 1998, sumatriptan had been used to treat more than 236 million migraine attacks world-wide. In clinical trials alone, more than 88000 migraine patients had treated more than 300000 migraine attacks with sumatriptan, and 2000 normal h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9dd4209bd9dacd29ff5ab96d3906b494
https://pubmed.ncbi.nlm.nih.gov/11737014
https://pubmed.ncbi.nlm.nih.gov/11737014
Autor:
N T, Mathew
Publikováno v:
Health news (Waltham, Mass.). 6(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea37b00f9e5fee8e8c5559ef40186cca
https://pubmed.ncbi.nlm.nih.gov/10932653
https://pubmed.ncbi.nlm.nih.gov/10932653
Autor:
N T, Mathew, R, Salonen
Publikováno v:
International journal of clinical practice. Supplement. 105
Oral sumatriptan, which is a well tolerated, effective acute treatment for migraine, and is selectively available in different countries in 100 mg, 50 mg, and 25 mg tablets. The first large dose-ranging study compared the 100 mg dose to higher doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9c4bcf6cda969c60dffd4ef41703185
https://pubmed.ncbi.nlm.nih.gov/10692716
https://pubmed.ncbi.nlm.nih.gov/10692716
Autor:
N T, Mathew
Publikováno v:
Cephalalgia : an international journal of headache. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1041b7fd44513c78194798bd88542687
https://pubmed.ncbi.nlm.nih.gov/9533668
https://pubmed.ncbi.nlm.nih.gov/9533668
Publikováno v:
Neurology. 49(6)
The efficacy and tolerability of naratriptan tablets (2.5 mg, 1 mg, and 0.25 mg) compared with placebo in the acute treatment of migraine were evaluated in a randomized, double-blind, four-period crossover study. Five hundred eighty-six assessable pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5d7ef9d56488fdb23f0555a2a53db93
https://pubmed.ncbi.nlm.nih.gov/10214771
https://pubmed.ncbi.nlm.nih.gov/10214771
Publikováno v:
Neurology. 49(5)
This study investigated the efficacy of zolmitriptan (Zomig, formerly 311C90) in acute migraine therapy. Patients with a history of migraine were randomized in a double-blind, multicenter, placebo-controlled, dose range-finding study of oral zolmitri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cea14defb72862cc7baeea131f06e7d1
https://pubmed.ncbi.nlm.nih.gov/9371890
https://pubmed.ncbi.nlm.nih.gov/9371890
Autor:
N T, Mathew
Publikováno v:
Headache. 37
Ergotamine tartrate (ET) and dihydroergotamine (DHE) are effective therapies for migraine and cluster headache. Optimal management with these agents must take several factors into account, including headache type and severity, associated symptoms, si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45575dfc7f085cc82973e37b4b8d375c
https://pubmed.ncbi.nlm.nih.gov/9009471
https://pubmed.ncbi.nlm.nih.gov/9009471